Tag: U.S.

EIT Emerging Implant Technologies Moves Toward Commercialization of its 3D Printed Cellular Titanium Implants in the United States
Spine Top Stories

EIT Emerging Implant Technologies Moves Toward Commercialization of its 3D Printed Cellular Titanium Implants in the United States

Emerging Implant Technologies GmbH (EIT), a German medical device manufacturer exclusively focused on creating innovative technologies for spinal application by utilizing additive manufacturing, announces major milestones in preparation of its expected 510(k) approval later this year. EIT Cellular Titanium® is a porous titanium structure that has been designed according to […]

BoneSupport TM extends U.S. Distribution agreement for Cerament TM Bone Void Filler
Biologics Top Stories

BoneSupport TM extends U.S. Distribution agreement for Cerament TM Bone Void Filler

Lund, Sweden, 14 March, 2017 – BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone scaffolds to treat bone voids caused by trauma, infection, disease or related surgery, announces that it has extended the term of its U.S. distribution agreement with Zimmer Biomet.  Under the agreement, Zimmer Biomet will continue […]

Alphatec’s Arsenal™ Deformity Adolescent Scoliosis (AIS) System Launched in Limited Markets in the U.S.
Spine

Alphatec’s Arsenal™ Deformity Adolescent Scoliosis (AIS) System Launched in Limited Markets in the U.S.

CARLSBAD, Calif., Feb. 28, 2017 (GLOBE NEWSWIRE) — Alphatec Spine, Inc., (Nasdaq:ATEC), a global provider of spinal fusion technologies, announced today that the Company has launched its new Arsenal Deformity Adolescent Idiopathic Scoliosis (AIS) System and has successfully completed initial patient cases.  The limited release further expands the Company’s Arsenal […]

Tissue Regenix Introduces Revolutionary dCELL® Platform Technology to the United States
Biologics Top Stories

Tissue Regenix Introduces Revolutionary dCELL® Platform Technology to the United States

February 23, 2017 09:03 AM Eastern Standard Time SAN ANTONIO–(BUSINESS WIRE)–Tissue Regenix, the U.K.-based leader in regenerative medicine, has established its decellularization (dCELL®) Technology in wound care in the United States with plans to expand into other medical sectors. The company has opened up new possibilities in regenerative medicine in […]

VEXIM: another major step towards the SpineJack® commercialization in the US
Spine

VEXIM: another major step towards the SpineJack® commercialization in the US

Toulouse, February 21st, 2017 (8:00AM CET) – VEXIM (FR0011072602 – ALVXM), a medical device company specializing in the minimally-invasive treatment of vertebral fractures, today announces enrollment completion of its FDA clinical trial. The VEXIM FDA trial is a European, prospective and randomized multicenter study. It aims to compare safety and […]

Vericel Announces First MACI Implant in the United States for the Treatment of Symptomatic Cartilage Defects of the Knee
Extremities

Vericel Announces First MACI Implant in the United States for the Treatment of Symptomatic Cartilage Defects of the Knee

CAMBRIDGE, Mass., Feb. 01, 2017 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases and conditions, today announced the first implant of MACI®(autologous cultured chondrocytes on porcine collagen membrane) in the United States for the repair of […]

UK based medical device company announces two new patents granted by the US Patent and Trademark Office
Regulatory

UK based medical device company announces two new patents granted by the US Patent and Trademark Office

SIRAKOSS Ltd., a UK-based medical device company developing innovative bone grafting solutions for the $3 billion global orthopaedic market, has announced that the United States Patent and Trademark Office (USPTO) has granted two  patents for its bone graft technologies.  SIRAKOSS‘ patent portfolio encompasses advanced synthetic bone graft technologies which  form […]

Amplitude Surgical Announces That is Has Been Granted Approval to Market Its Anatomic® Total Knee Prosthesis in the United States
Regulatory

Amplitude Surgical Announces That is Has Been Granted Approval to Market Its Anatomic® Total Knee Prosthesis in the United States

January 20, 2017 VALENCE, France–(BUSINESS WIRE)–Regulatory News: Amplitude Surgical (Paris:AMPLI) (ISIN: FR0012789667, Ticker: AMPLI, PEA-PME eligible), a leading French player on the global surgical technology market for lower-limb orthopedics, today announces that it has received 510(k) regulatory clearance from the US Food and Drug Administration (FDA) for its Anatomic® implant, […]

Spine

VEXIM Strengthens its Management Team

January 19, 2017 VEXIM (Paris:ALVXM) (FR0011072602 – ALVXM / PEA‐PME eligible), a medical device company specializing in the minimally invasive treatment of vertebral fractures, today announces the appointment of Russell Powers as Vice President and General Manager of its US business, effective January 1st, 2017. Russell brings more than 25 […]

US District Court Rules in Favor of CoorsTek Medical in Ceramic Hip Implant Lawsuit Clearing the Path for CeraSurf®-p Ceramic Hip Implants in the US
Regulatory

US District Court Rules in Favor of CoorsTek Medical in Ceramic Hip Implant Lawsuit Clearing the Path for CeraSurf®-p Ceramic Hip Implants in the US

January 17, 2017 FORT WORTH, Texas–(BUSINESS WIRE)– CoorsTek Medical, a leading US manufacturer of advanced implantable ceramic components, today announced that the United States District Court for the District of Colorado has ruled in favor of CoorsTek Medical in its lawsuit challenging the trademark and trade dress claims of CeramTec […]

With increasing incidence of bone and joint diseases and injuries, Regenerative Medicine Market is predicted to reach US $6.5B by 2019
Biologics

With increasing incidence of bone and joint diseases and injuries, Regenerative Medicine Market is predicted to reach US $6.5B by 2019

JANUARY 14TH, 2017 –  TRANSPARENCY MARKET RESEARCH The report presents a detailed summary of the historical development trajectory exhibited by the global regenerative medicine market and explains the market’s present condition through industry-standard analytical tools. A solid analysis of the market’s statistics is used to derive reliable forecasts regarding the […]

Aurora Spine’s Patent Related to Its Polyaxial ZIP® ISP Allowed by the United States Patent Office
Regulatory

Aurora Spine’s Patent Related to Its Polyaxial ZIP® ISP Allowed by the United States Patent Office

CARLSBAD, Calif., Jan. 13, 2017 (GLOBE NEWSWIRE) — Aurora Spine Corporation (TSXV:ASG) announced today the allowance of its United States Patent Application No.: 14/732,240 entitled “POLYAXIAL INTERSPINOUS FUSION IMPLANT AND BONE GROWTH STIMULATION SYSTEM.”   In addition to Aurora’s implant family of ZIP® ISPs, including its ZIP Ultra®, ZIP 51™, […]

SPINEWAY : Signature of a new distribution agreement in the US
Spine

SPINEWAY : Signature of a new distribution agreement in the US

Press release                                                                                                                          Ecully, 10 January 2017 Signature of a new distribution agreement in the US Spineway, specialist in surgical implants and instruments for treating disorders of the spinal column (spine), announces the signature of a distribution agreement with a new partner based in Dallas. This contract concerns the sale of […]